Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
analysts
Financials
Sanofi, GSK and Novo benefit from currency changes: analyst
For certain European drugmakers such as Sanofi and GSK, the stronger dollar should help their financials, the ODDO team said.
Zoey Becker
Oct 21, 2022 9:21am
Pfizer's Paxlovid came up short in a COVID prophylaxis study
May 2, 2022 10:00am
Novartis hires Bernstein analyst Ronny Gal as new M&A czar
Apr 26, 2022 3:11am
With Aduhelm slapped down by CMS, what's next for Biogen?
Apr 8, 2022 7:40am
Lilly, AbbVie set for success late in decade, but BMS may suffer
Apr 7, 2022 3:15pm
How world events may shape pharma revenues in the months to come
Apr 5, 2022 8:20am